Neurons 3D Rendering

Discuss your clinical development program.

CNS, psychiatry and neurology trials often depend on specialized procedures, subjective endpoint collection, trained raters and close coordination across clinical, operational and data teams. DVCR supports sponsors with experienced oversight, responsive study teams and integrated services designed to protect study quality from startup through reporting.

CNS-focused experience

DVCR’s investigators have participated in hundreds of psychiatric and neurologic clinical studies across all phases of research.

Scientific and medical oversight

CNS programs are supported by experienced leaders familiar with CNS drug classes, mechanisms of action, patient populations, procedures and assessments.

Specialized assessments

Study teams support CNS-specific procedures and scales including VAS, CSF sampling, PSG, EEG, CADSS, BPRS, MOAA/S, HAM-D, MADRS, ADAS-Cog, ADHD-RS, CGI, PHQ-9 and C-SSRS.

Early phase CRO support

DVCR supports FIH, SAD/MAD, NDA-enabling clinical pharmacology, HAP/HAL, Phase Ib/IIa proof-of-concept, Phase I-II multi-site patient trials and analog classroom studies for ADHD.

Integrated study execution

Project management, data management, biostatistics, statistical programming, PK/PD analysis and modeling, clinical and medical monitoring, medical writing as well as site feasibility, management and central laboratory services for Phase I-II multi-site trials with our global network of site partners.

Technology-enabled data quality

Integrated systems support real-time data capture, sponsor visibility, audit-ready documentation and cleaner study conduct.

Clinical research exam room with medical monitors displaying patient vitals

Key capabilities include:

DVCR supports CNS clinical trials across multiple psychiatric and neurologic indications, with strategic site partners for multi-site patient trials.

  • Depression, including TRD and MDD
  • Bipolar disorder
  • Schizophrenia
  • ADHD, including adult and pediatric populations
  • Substance abuse disorders
  • Epilepsy
  • Alzheimer’s disease and dementia
  • Parkinson’s disease